Martek
This article was originally published in The Tan Sheet
Executive Summary
Company's nutritional oils enriched with docosahexaenoic acid (DHA) and arachidonic acid (ARA) will be sold in term infant formulas in the U.K., Martek Biosciences announces March 6. Wyeth Nutritionals International, a subsidiary of Wyeth-Ayerst Pharmaceuticals, will include ingredients in SMA Gold term infant formula. FDA is reviewing DHA/ARA as ingredients in formulas to be marketed in U.S.; Martek expects a decision within the year. The firm also announces March 2 completion of approximately $20 mil. in financing with investor group, selling over 1.2 mil. shares of its common stock and issuing warrants to purchase 319,811 shares